Cuál es el precio por Jenkem Technology Co., Ltd. (688356)

Precio por Jenkem Technology Co., Ltd. (688356) es de$15.77

Cuál es la capitalización de mercado por Jenkem Technology Co., Ltd. (688356)

Capitalización de mercado por Jenkem Technology Co., Ltd. (688356) es $956.26M

Jenkem Technology Co., Ltd. (688356) Desdoblamientos de Acciones

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG products; monodisperse PEG products consisting of methoxy monodisperse PEG derivatives, and monodisperse PEG derivatives with the same functional and heterofunctional groups; click chemistry; lipid nanoparticles delivery system accessories; PEG linkers, such as ADC and PROTAC linkers; PEG medical devices, which include multi-arm PEG derivatives; polyethylene glycol standards; block copolymers; PEG standards; long-acting polypeptide fatty acid side chains, including semaglutide, tirzepatide/icodec, and somapacitan intermediates; and Silkrose injectable cross-linked sodium hyaluronate gel, a passive implantable device used to correct moderate to severe nasolabial folds through subcutaneous injection. It also provides technical services comprising development of synthetic methods, quality research and IND application, analytical method development, and polyethylene glycolization technology services. Jenkem Technology Co., Ltd. was incorporated in 2001 and is headquartered in Beijing, China.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
Not enough data for the provided dates.

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

Not enough data for the provided dates.

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
Royalty Pharma plc RPRX.US	0	-	US
Swedish Orphan Biovitrum AB SOBI.ST	0	-	SE
Ipsen S.A. IPN.PA	0	-	FR
Sino Biopharmaceutical Limited 1177.HK	7	x40	HK
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0	-	IT

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País